Showing results (31-40 of 84) with videos related to
Sort By:
Pageof 9
Modern Rheumatology|May 21, 2011
Guidance on using tocilizumab for juvenile idiopathic arthritisShumpei Yokota, Tomoyuki Imagawa, Syuji Takei, et al.Modern Rheumatology|October 12, 2007
Proposal for juvenile idiopathic arthritis guidance on diagnosis and treatment for primary care pediatricians and nonpediatric rheumatologists (2007)Shumpei Yokota, Masaaki Mori, Tomoyuki Imagawa, et al.The Journal of Rheumatology|June 2, 2004
Antiagalactosyl IgG antibodies in juvenile idiopathic arthritis, juvenile onset Sjögren's syndrome, and healthy childrenNobuaki Maeno, Syuji Takei, Satoshi Fujikawa, et al.Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|September 1, 2020
Pediatric Dual-Energy X-Ray Absorptiometry in Japan: A Proposal for Shared Access to EquipmentToru Igarashi, Syuji Takei, Eriko Tanaka, et al.Modern Rheumatology|October 17, 2015
Prediction of long-term remission of oligo/polyarticular juvenile idiopathic arthritis with S100A12 and vascular endothelial growth factorYuichi Yamasaki, Syuji Takei, Hiroyuki Imanaka, et al.Annals of the Rheumatic Diseases|December 2, 2017
Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study)Yoshikazu Nakaoka, Mitsuaki Isobe, Syuji Takei, et al.Pediatric Rheumatology Online Journal|February 19, 2025
Safety and effectiveness of intravenous abatacept for polyarticular-course juvenile idiopathic arthritis: An all-case postmarketing surveillance studyTomo Nozawa, Naomi Iwata, Toru Igarashi, et al.Frontiers in Immunology|June 17, 2022
Potential Benefits of TNF Targeting Therapy in Blau Syndrome, a NOD2-Associated Systemic Autoinflammatory GranulomatosisTomoko Matsuda, Naotomo Kambe, Riko Takimoto-Ito, et al.Modern Rheumatology|April 29, 2020
Safety and effectiveness of adalimumab in Japanese patients with juvenile idiopathic arthritis: Results from a real-world postmarketing studySyuji Takei, Naomi Iwata, Ichiro Kobayashi, et al.Modern Rheumatology|September 26, 2008
Methotrexate for the treatment of juvenile idiopathic arthritis: process to approval for JIA indication in JapanMasaaki Mori, Takuya Naruto, Tomoyuki Imagawa, et al.Pageof 9